RW3 Quantitative Bias Analysis (QBA) for Comparative Effectiveness of Alectinib versus Ceritinib in Non-Small Cell Lung Cancer (NSCLC)
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.1202
https://www.valueinhealthjournal.com/article/S1098-3015(21)01419-4/fulltext
Title :
RW3 Quantitative Bias Analysis (QBA) for Comparative Effectiveness of Alectinib versus Ceritinib in Non-Small Cell Lung Cancer (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01419-4&doi=10.1016/j.jval.2021.04.1202
First page :
Section Title :
Open access? :
No
Section Order :
10684